Study of NMS-1286937 in Adult Patients With Advanced/Metastatic Solid Tumors
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and tolerability of NMS-1286937, a
polo-like-kinase 1 inhibitor, in patients with advanced metastatic solid tumor.